Padosev IV infusion 20mg, manufactured by Astellas Pharma, contains Enfortumab vedotin (genetical recombination). This antibody-drug conjugate works by targeting Nectin-4, a protein expressed on cancer cells, to deliver a cytotoxic agent that causes cell cycle arrest and apoptosis. It is supplied as 20mg per bottle, with YJ code 4291459D2027.
Padosev IV infusion 20mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
